| Description: |
circCDYL is up-regulated in breast cancer tissues versus adjacent normal tissues and is measurable by both the CRISPR nanoswitch and RT-qPCR. Its levels contribute to diagnostic discrimination and, together with circMTO1, enable grouping of patients by stage/progression. |